Results 111 to 120 of about 40,978 (301)

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

ESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad, Jeanne du Fay de Lavallaz, Michael J. Zhang, Thanat Chaikijurajai, Bo Ye, Prabhjot S. Nijjar, Julie A. Lahiri, Cindy M. Martin, Tamas Alexy, Markus Meyer   +9 more
wiley   +1 more source

P-147 Positioning the atrial lead at the interatrial septum — initial experience with a special implantation technique [PDF]

, 2003
W. Daenschel, Heiko Stellmach, H.K. Kleinertz   +2 more
openalex   +1 more source

The use of echocardiography and echocardiographic findings in patients hospitalized for acute heart failure

ESC Heart Failure, EarlyView.
Abstract Aims Transthoracic echocardiography (TTE) is recommended as a key investigation in patients with acute heart failure (AHF) in major guidelines. However, utilization and benefits are yet to be known in Thai patients. The study aims to evaluate the benefits of TTE and identify factors associated with the decision to perform TTE on patients with ...
Koravich Lorlowhakarn, Thanaporn Ratchataswan, Thiratest Leesutipornchai, Aunchalee Jaroenlapnopparat, Palapun Waitayangkoon, Supanee Sinphurmsukskul, Sarawut Siwamogsatham, Sarinya Puwanant, Smonporn Boonyaratavej Songmuang, Aekarach Ariyachaipanich   +9 more
wiley   +1 more source

Atrial Appendage Anastomosis in Hypoplastic Left Heart Syndrome With Restrictive Atrial Septum: A Novel Approach. [PDF]

JACC Case Rep, 2022
Nguyen CP, Tai CP, Moon-Grady AJ, Reddy VM.   +3 more
europepmc   +1 more source

Creation of an Atrial Septal Defect In Utero for Fetuses With Hypoplastic Left Heart Syndrome and Intact or Highly Restrictive Atrial Septum [PDF]

, 2004
Audrey C. Marshall, Mary E. van der Velde, Wayne Tworetzky, Carlen A. Gomez, Louise Wilkins‐Haug, Carol B. Benson, Russell W. Jennings, James E. Lock   +7 more
openalex   +1 more source

Prognostic utility of advanced lung cancer inflammation index in heart failure with preserved ejection fraction

ESC Heart Failure, EarlyView.
The advanced lung cancer inflammation index (ALI) is an integrated marker of inflammation and nutritional status, calculated by body mass index × serum albumin / neutrophil‐to‐lymphocyte ratio. Low ALI levels were significantly associated with poor prognosis in elderly multimorbid HFpEF patients.
Daisuke Sakamoto, Yuki Matsuoka, Masahiro Seo, Takahisa Yamada, Daisaku Nakatani, Katsuki Okada, Akihiro Sunaga, Hirota Kida, Taiki Sato, Tetsuhisa Kitamura, Shunsuke Tamaki, Masamichi Yano, Takaharu Hayashi, Akito Nakagawa, Yusuke Nakagawa, Yoshio Yasumura, Shungo Hikoso, Yohei Sotomi, Yasushi Sakata, on behalf of the OCVC‐Heart Failure Investigators   +19 more
wiley   +1 more source

Right Atrial Septal In Situ Microthrombus: A Potential Novel Cause of Patent Foramen Ovale‐Associated Stroke

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Patent foramen ovale (PFO)‐associated stroke has a complex and diverse pathogenesis. It mainly results from a paradoxical embolism caused by venous thrombosis.
Jianbo Zhu, Anni Chen, Lei Zhu, Yun Li, Zhenzhen Jiang, Dijia Ni, Yuanyuan Zheng, Xiatian Liu   +7 more
doaj   +1 more source

Visualization of Double Atrial Septum with Persistent Interatrial Space by Three- Dimensional Transesophageal Echocardiography. [PDF]

Anatol J Cardiol, 2022
Gao L, He L, Fang L, Xie M, Lin Y, Li Y.
europepmc   +1 more source

Post-infarct rupture of the membranous ventricular septum complicated by left atrial dissection [PDF]

, 2005
E.W. Matthias Kirsch, Emmanuelle Vermès, D Loisance   +2 more
openalex   +1 more source

Lower left ventricular ejection time in MYBPC3 variant carriers with overt or subclinical hypertrophic cardiomyopathy

ESC Heart Failure, EarlyView.
Abstract Aims Hypertrophic cardiomyopathy (HCM) is an inherited cardiomyopathy often caused by pathogenic variants in MYBPC3 and MYH7, encoding myosin‐binding protein C3 and myosin heavy chain 7, respectively. These variants can cause increased actin–myosin crossbridge cycling, resulting in ventricular hypercontractility, but mice lacking Mybpc3 ...
Isabell Yan, Zoe Möhring, Daniel Reichart, Fanny Kortüm, Julia Münch, Rixa Woitschach, Paulus Kirchhof, Lucie Carrier, Carolyn Y. Ho, Thomas Eschenhagen, Monica Patten   +10 more
wiley   +1 more source